Peptide Synthesis IndustryThe global peptide synthesis market is poised for significant growth, with its valuation projected to increase from USD 520.0 million in 2023 to an impressive USD 1.1 billion ...

Juan José González, CEO of PolyPeptide: “The large-scale capacity expansion in Malmö allows us to further deepen the long-standing collaboration with an important GLP-1 customer. We are making good ...

BrisSynBio has two CEM Liberty Blue automated, microwave-assisted peptide synthesisers. These support Fmoc peptide synthesis of sequences from two to about fifty residues at a scale from one to about ...

BrisSynBio’s first spin-out company, Zentraxa, has developed a peptide ... around developing tractable routes to producing increasingly complex peptides, increasing peptide synthesis capability, and a ...

The acquisition also allows AbbVie to utilize Nimble's proprietary peptide synthesis platform to enable ... meaningful revenues that are boosting the company’s top line. In the first nine ...

Peptide Therapeutics MarketThe global peptide therapeutics market is on a strong growth trajectory, with sales projected to ...

In addition to acquiring Nimble's drug candidates, AbbVie will gain access to the company's advanced peptide synthesis, screening, and optimization platform. Nimble's roots trace back to 1999 ...

The North Chicago, Ill., company said is also acquiring Nimble's peptide synthesis, screening and optimization platform, which uses proprietary technology to help drive rapid discovery and ...

In addition, chemical synthesis is the only technique that ... presumably because it is currently the only option for longer peptides. One such company, Allelix Pharmaceuticals (Mississauga ...

Proposed acquisition adds Nimble's lead asset, an investigational oral peptide IL23R inhibitor in preclinical development for psoriasis, and a pipeline of other novel oral peptide assets across ...

In a significant step towards advancing scientific research, InfinityChem has unveiled its latest research and manufacturing facility in Scottsdale, Arizona. The new facility is primed to produce ...

The North Chicago, Ill., company said is also acquiring Nimble's peptide synthesis, screening and optimization platform, which uses proprietary technology to help drive rapid discovery and ...